Literature DB >> 27274624

Proteomic Findings in Melanoma.

Deepanwita Sengupta1, Alan J Tackett2.   

Abstract

Although the emergence of proteomics as an independent branch of science is fairly recent, within a short period of time it has contributed substantially in various disciplines. The tool of mass spectrometry has become indispensable in the analysis of complex biological samples. Clinical applications of proteomics include detection of predictive and diagnostic markers, understanding mechanism of action of drugs as well as resistance mechanisms against them and assessment of therapeutic efficacy and toxicity of drugs in patients. Here, we have summarized the major contributions of proteomics towards the study of melanoma, which is a deadly variety of skin cancer with a high mortality rate.

Entities:  

Keywords:  Biomarkers; Mass spectrometry; Melanoma; Proteomics

Year:  2016        PMID: 27274624      PMCID: PMC4888906          DOI: 10.4172/jpb.1000e29

Source DB:  PubMed          Journal:  J Proteomics Bioinform        ISSN: 0974-276X


  36 in total

1.  Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.

Authors:  Diana Abdueva; Michele Wing; Betty Schaub; Timothy Triche; Elai Davicioni
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

2.  PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks.

Authors:  Linsey M Raaijmakers; Piero Giansanti; Patricia A Possik; Judith Mueller; Daniel S Peeper; Albert J R Heck; A F Maarten Altelaar
Journal:  J Proteome Res       Date:  2015-09-08       Impact factor: 4.466

3.  Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.

Authors:  Yijing Yu; Ioannis Prassas; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

4.  A targeted quantitative proteomics strategy for global kinome profiling of cancer cells and tissues.

Authors:  Yongsheng Xiao; Lei Guo; Yinsheng Wang
Journal:  Mol Cell Proteomics       Date:  2014-02-11       Impact factor: 5.911

5.  Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.

Authors:  Anne-Lise Steunou; Manuelle Ducoux-Petit; Ikrame Lazar; Bernard Monsarrat; Monique Erard; Catherine Muller; Eric Clottes; Odile Burlet-Schiltz; Laurence Nieto
Journal:  Mol Cell Proteomics       Date:  2012-12-28       Impact factor: 5.911

6.  Periostin accelerates human malignant melanoma progression by modifying the melanoma microenvironment.

Authors:  Yorihisa Kotobuki; Lingli Yang; Satoshi Serada; Atsushi Tanemura; Fei Yang; Shintaro Nomura; Akira Kudo; Kenji Izuhara; Hiroyuki Murota; Minoru Fujimoto; Ichiro Katayama; Tetsuji Naka
Journal:  Pigment Cell Melanoma Res       Date:  2014-04-22       Impact factor: 4.693

7.  Cytotoxic mechanisms of panduratin A on A375 melanoma cells: A quantitative and temporal proteomics analysis.

Authors:  Siew-Li Lai; Pooi-Fong Wong; Teck-Kwang Lim; Qingsong Lin; Mohd Rais Mustafa
Journal:  Proteomics       Date:  2015-03-30       Impact factor: 3.984

Review 8.  Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma.

Authors:  Verena Paulitschke; Ossia Eichhoff; Phil F Cheng; Mitchell P Levesque; Christoph Höller
Journal:  Curr Opin Oncol       Date:  2016-03       Impact factor: 3.645

9.  Identifying mRNA, microRNA and protein profiles of melanoma exosomes.

Authors:  Deyi Xiao; Joanna Ohlendorf; Yinlu Chen; Douglas D Taylor; Shesh N Rai; Sabine Waigel; Wolfgang Zacharias; Hongying Hao; Kelly M McMasters
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

10.  Proteomics in melanoma biomarker discovery: great potential, many obstacles.

Authors:  Michael S Sabel; Yashu Liu; David M Lubman
Journal:  Int J Proteomics       Date:  2011-10-11
View more
  4 in total

Review 1.  Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.

Authors:  Rongrong Huang; Zhongsi Chen; Lei He; Nongyue He; Zhijiang Xi; Zhiyang Li; Yan Deng; Xin Zeng
Journal:  Theranostics       Date:  2017-08-18       Impact factor: 11.556

2.  Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy.

Authors:  Inês P Santos; Remco van Doorn; Peter J Caspers; Tom C Bakker Schut; Elisa M Barroso; Tamar E C Nijsten; Vincent Noordhoek Hegt; Senada Koljenović; Gerwin J Puppels
Journal:  Br J Cancer       Date:  2018-11-09       Impact factor: 7.640

Review 3.  Clinical Implications of Primary Cilia in Skin Cancer.

Authors:  Abrar Choudhury; Neil M Neumann; David R Raleigh; Ursula E Lang
Journal:  Dermatol Ther (Heidelb)       Date:  2020-01-29

4.  Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression.

Authors:  Erin M Taylor; Stephanie D Byrum; Jacob L Edmondson; Christopher P Wardell; Brittany G Griffin; Sara C Shalin; Murat Gokden; Issam Makhoul; Alan J Tackett; Analiz Rodriguez
Journal:  Acta Neuropathol Commun       Date:  2020-09-05       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.